Search research articles
Contact Us
Filters
Showing results (101-110 of 137) with videos related to
Page
of 14
Sort By:
Oncotarget
|
February 6, 2019
Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy
Hui-Zi Chen, Russell Bonneville, Lianbo Yu, et al.
Nature Communications
|
July 6, 2021
Purkinje cell axonal swellings enhance action potential fidelity and cerebellar function
Daneck Lang-Ouellette, Kim M Gruver, Amy Smith-Dijak, et al.
Astrobiology
|
August 10, 2019
Phobos LIFE (Living Interplanetary Flight Experiment)
Bruce H Betts, David Warmflash, Raymond E Fraze, et al.
Neuro-Oncology
|
May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma
Ute Bartels, Johannes Wolff, Lia Gore, et al.
European Journal of Haematology
|
December 9, 2025
A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation
Aseel Alsouqi, Ying Huang, Beth Christian, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2022
Inflammation-related pathology in the olfactory epithelium: its impact on the olfactory system in psychotic disorders
Kun Yang, Yuto Hasegawa, Janardhan P Bhattarai, et al.
Molecular Psychiatry
|
February 6, 2024
Inflammation-related pathology in the olfactory epithelium: its impact on the olfactory system in psychotic disorders
Kun Yang, Yuto Hasegawa, Janardhan P Bhattarai, et al.
Targeted Oncology
|
June 17, 2022
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study
Tanya Trippett, Helen Toledano, Quentin Campbell Hewson, et al.
NPJ Precision Oncology
|
September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer
Leah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
Human Molecular Genetics
|
July 6, 2016
An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes
Amber L Southwell, Amy Smith-Dijak, Chris Kay, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 137) with videos related to
Sort By:
Page
of 14
Oncotarget
|
February 6, 2019
Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy
Hui-Zi Chen, Russell Bonneville, Lianbo Yu, et al.
Nature Communications
|
July 6, 2021
Purkinje cell axonal swellings enhance action potential fidelity and cerebellar function
Daneck Lang-Ouellette, Kim M Gruver, Amy Smith-Dijak, et al.
Astrobiology
|
August 10, 2019
Phobos LIFE (Living Interplanetary Flight Experiment)
Bruce H Betts, David Warmflash, Raymond E Fraze, et al.
Neuro-Oncology
|
May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma
Ute Bartels, Johannes Wolff, Lia Gore, et al.
European Journal of Haematology
|
December 9, 2025
A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation
Aseel Alsouqi, Ying Huang, Beth Christian, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2022
Inflammation-related pathology in the olfactory epithelium: its impact on the olfactory system in psychotic disorders
Kun Yang, Yuto Hasegawa, Janardhan P Bhattarai, et al.
Molecular Psychiatry
|
February 6, 2024
Inflammation-related pathology in the olfactory epithelium: its impact on the olfactory system in psychotic disorders
Kun Yang, Yuto Hasegawa, Janardhan P Bhattarai, et al.
Targeted Oncology
|
June 17, 2022
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study
Tanya Trippett, Helen Toledano, Quentin Campbell Hewson, et al.
NPJ Precision Oncology
|
September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer
Leah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
Human Molecular Genetics
|
July 6, 2016
An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes
Amber L Southwell, Amy Smith-Dijak, Chris Kay, et al.
Page
of 14